Stereotaxis (STXS) Income from Continuing Operations (2010 - 2026)
Stereotaxis (STXS) reported Income from Continuing Operations of 5981000.0 for Q1 2026, down 0.88% year-over-year from 6033920.2 in Q1 2025, and down 5.88% quarter-over-quarter from 5649000.0 in Q4 2025.
Stereotaxis (STXS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Income from Continuing Operations data on file, last reported at 5981000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 5981000.0, down 0.88% year-over-year; the trailing twelve-month figure through Mar 2026 was 22164000.0 (up 14.5% YoY), and the FY2025 annual result was 22112000.0, up 10.62% from the prior year.
- Income from Continuing Operations slipped to 5981000.0 in Q1 2026 per STXS's latest filing, from 5649000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 3977000.0 in Q2 2025 and troughed at 7627000.0 in Q4 2024.
- A 5-year average of 5496882.35 and a median of 5619000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations tumbled 167.6% in 2022, then surged 33.95% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 4456000.0 in 2022, then fell by 19.03% to 5304000.0 in 2023, then tumbled by 43.8% to 7627000.0 in 2024, then climbed by 25.93% to 5649000.0 in 2025, then slipped by 5.88% to 5981000.0 in 2026.
- Business Quant data shows STXS's Income from Continuing Operations at 5981000.0 in Q1 2026, 5649000.0 in Q4 2025, and 6557000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | -5.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.98 Mn |
| Dec 31, 2025 | -5.65 Mn |
| Sep 30, 2025 | -6.56 Mn |
| Jun 30, 2025 | -3.98 Mn |
| Mar 31, 2025 | -5.93 Mn |
| Dec 31, 2024 | -7.63 Mn |
| Sep 30, 2024 | -6.35 Mn |
| Jun 30, 2024 | -6.02 Mn |
| Mar 31, 2024 | -4.75 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -5.28 Mn |
| Mar 31, 2023 | -5.62 Mn |
| Dec 31, 2022 | -4.46 Mn |
| Sep 30, 2022 | -5.05 Mn |
| Jun 30, 2022 | -5.18 Mn |
| Mar 31, 2022 | -4.09 Mn |
| Dec 31, 2021 | -3.35 Mn |
| Sep 30, 2021 | -4.62 Mn |
| Jun 30, 2021 | -3.39 Mn |